Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Nutr Clin Pract ; 37(5): 1074-1087, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35997322

RESUMEN

Advancements in respiratory and nutrition management have significantly improved the survival of patients with cystic fibrosis (CF). With the availability of several nutrition interventions such as oral/enteral nutrition supplements, enteric-coated pancreatic enzymes, and water-miscible CF-specific vitamin supplements, frank vitamin deficiencies-with the exception of vitamin D-are rarely encountered in current clinical practice. Whereas they were previously considered as micronutrients, our current understanding of fat-soluble vitamins and minerals as antioxidants, immunomodulators, and disease biomarkers has been evolving. The impact of highly effective modulators on the micronutrient status of patients with CF remains elusive. This narrative review focuses on the updates on the management of fat-soluble vitamins and other micronutrients in CF in the current era and identifies the gaps in our knowledge.


Asunto(s)
Fibrosis Quística , Vitaminas , Fibrosis Quística/terapia , Suplementos Dietéticos , Humanos , Micronutrientes/uso terapéutico , Minerales/uso terapéutico , Vitamina A , Vitaminas/uso terapéutico
3.
Nutr Clin Pract ; 37(2): 344-350, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35199869

RESUMEN

BACKGROUND: Patients with cystic fibrosis (CF) and pancreatic insufficiency are at risk for suboptimal fat absorption, inability to maintain weight, poor growth, and increased gastrointestinal (GI) symptoms due to malabsorption. Enteral nutrition (EN) is used to supplement caloric intake and requires pancreatic enzyme replacement for effective digestion. We evaluated the relationship between long-term use of an in-line digestive enzyme cartridge with EN and changes in anthropometric measures and GI symptoms in patients with CF. METHODS: This is a single-center, retrospective case review of patients with CF using a digestive enzyme cartridge with EN. Data were collected from the patient medical records and included weight, height, body mass index, EN regimen, and reported GI symptoms. RESULTS: Thirteen pediatric and five adult patients with a mean age of 12.6 years used a digestive enzyme cartridge with EN for a period of 3-27 months. Most patients (n = 14) had been using oral digestive enzymes with EN before using the digestive enzyme cartridge, whereas four started from the onset of EN. The indications to convert from oral enzymes to the digestive enzyme cartridge included poor growth (72.2%) and poor tolerance of EN (69.2%). There was a reduction in reported GI symptoms after initiating use of the digestive enzyme cartridge. After 12 months of digestive cartridge use, there were improvements in anthropometrics. CONCLUSIONS: This real-world experience with prolonged use of a digestive enzyme cartridge with EN demonstrated improved clinical outcomes and a reduction in GI symptoms in patients with CF.


Asunto(s)
Fibrosis Quística , Insuficiencia Pancreática Exocrina , Adulto , Niño , Fibrosis Quística/complicaciones , Fibrosis Quística/terapia , Nutrición Enteral , Insuficiencia Pancreática Exocrina/etiología , Insuficiencia Pancreática Exocrina/terapia , Fármacos Gastrointestinales/uso terapéutico , Humanos , Estudios Retrospectivos
4.
J Nutr Elder ; 27(1-2): 155-78, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18928195

RESUMEN

Our purpose was to evaluate a community-based fruit and vegetable intervention conducted in rural and urban areas of Georgia. Participants were a convenience sample from Georgia senior centers that completed a pre-test, the intervention, and a post-test (N = 558, mean age = 75, 83% female, 47% white, 53% black). The 4-month intervention had eight sessions focused on practical ways to increase intake of fruits and vegetables at meals and snacks and included physical activity. Pre- and post-tests examined self-reported intakes of fruits and vegetables at breakfast, lunch, the evening meal, and snacks, knowledge of recommended intakes, and barriers to intake. Following the intervention, the number of participants reporting consumption of at least 7 servings of fruits and vegetables daily increased by 21-percentage points (P < or = 0.001), knowledge that 7 to 10 servings of fruits and vegetables are recommended daily (for 1,600 to 2,200 calories) increased from 7% to 57% (P < or = 0.001), and three barriers to fruit and vegetable intake decreased (P < or = 0.05): "difficulties with digestion," "too many are recommended," and "too much trouble." Regression analyses indicated that increased intake following the intervention was independently associated with living in more urban rather than rural areas, improved knowledge of intake recommendations, decrease in perception of cost as a barrier, and increase in digestive problems as a barrier (P < or = 0.05). These results provide an evidence base for the effectiveness of this community intervention for improving knowledge and intake and decreasing barriers to fruit and vegetable intake in older adults.


Asunto(s)
Ingestión de Alimentos/psicología , Frutas , Evaluación Geriátrica/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Educación del Paciente como Asunto/métodos , Verduras , Anciano , Anciano de 80 o más Años , Encuestas sobre Dietas , Ingestión de Alimentos/fisiología , Conducta Alimentaria/fisiología , Conducta Alimentaria/psicología , Femenino , Georgia , Evaluación Geriátrica/métodos , Humanos , Masculino , Persona de Mediana Edad , Actividad Motora , Encuestas Nutricionales , Educación del Paciente como Asunto/estadística & datos numéricos , Características de la Residencia/estadística & datos numéricos , Población Rural , Población Urbana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...